Shariah compliance overview
HalalSupernus Pharmaceuticals, Inc. (SUPN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States.
Supernus Pharmaceuticals, Inc. (SUPN) operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 1.81% (limit 5%), interest-bearing debt is 18.63% (limit 30%) and interest-bearing securities and assets are 14.29% (limit 30%).
If you hold SUPN, give 1.81% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 1.81%Limit 5%Pass
- Interest-bearing debt
- 18.63%Limit 30%Pass
- Interest-bearing securities and assets
- 14.29%Limit 30%Pass
- Dividend purification
- 1.81%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Supernus Pharmaceuticals, Inc. (SUPN). Current Akinda screening label: Halal.
